Adverse Psychiatric Reactions to Modern Medication

Abstract

‘The trouble about always trying to preserve the health of the body is that it is so difficult to do without destroying the health of the mind.’

References

Ahlgren

(1977) Myelography with metrizamide in the cervical region. Acta Radiologica, Supplement 355, 98–104.

Ahmad

Sheikh

A. I.

Meeran

M. K.

(1979) Disopyramide-induced acute psychosis. Chest, 76, 712.

Alkana

R. L.

Parker

E. S.

Cohen

H. B.

Birch

Noble

E. P.

(1976) Reversal of ethanol intoxication in humans: an assessment of the efficacy of propranolol. Psychopharmacologia, 51, 29–37.

Ambrosino

S. V.

(1974) Depressive reactions associated with reserpine. New York State Medical Journal, 74, 860–864.

Amidsen

Schou

(1979) Lithium. In Side-effects of Drugs Annual Number 3 (ed. Dukes

M. N. G.

) pages 22–25. Excerpta Medica, Amsterdam.

Australian Prescriber (1980) Naproxen. 4, 44.

Ayd

F. J.

(1958) Drug-induced depression: fact or fallacy? New York State Journal of Medicine, 58, 354–356.

Baastrup

P. C.

Hollnagel

Sorensen

Schou

(1976) Adverse reactions in treatment with lithium carbonate and haloperidol. Journal of the American Medical Association, 236, 2645–2646.

Bailey

E. V.

Stone

T. W.

(1975) The mechanism of amantadine in parkinsonism: a review. Archives Internationales de Pharmacodynamic et Therapie, 216, 246–262.

10.

Baldessarini

R. J.

Lipinski

(1976) Definition of ‘dementia’ with haloperidol. New England Journal of Medicine, 295, 452.

11.

Baloch

(1974) Steroid psychosis: a case report. British Journal of Psychiatry, 124, 545–546.

12.

Bant

(1975) Diazepam withdrawal symptoms. British Medical Journal, 4, 285.

13.

Barbeau

(1971) Long-term side-effects of L-dopa. Lancet, 1, 395.

14.

Barnhart

Bowden

C. L.

(1979) Toxic psychosis with cimetidine. American Journal of Psychiatry, 136, 725–726.

15.

Baumgartner

Gavel

M. J.

Kaeser

H. E.

Pallis

C. A.

Rose

F. C.

Schaumberg

H. H.

Thomas

P. K.

Wadia

N. H.

(1979) Neuro-toxicity of halogenated hydroxyquinolines: clinical analysis of cases reported outside Japan. Journal of Neurology, Neurosurgery and Psychiatry, 42, 1073–1085.

16.

Beeley

(1980) Errors and misconceptions in drug prescribing. Journal of the Royal College of Physicians of London, 14, 58–64.

17.

Behrman

(1972) Mutism induced by phenothiazines. British Journal of Psychiatry, 121, 599–604.

18.

Bellair

G. H.

Smith

T. W.

Abelmann

H. W.

Harper

Hood

W. B.

(1971) Digitalis intoxication. New England Journal of Medicine, 28, 989–997.

19.

Berry

Garlett

E. L.

Bellet

Gifter

V. I.

(1951) Use of pronestyl in treatment of ectopic rhythms. American Journal of Medicine, 11, 431–441.

20.

Blazer

D. G.

Petrie

W. M.

Wilson

W. P.

(1976) Affective psychoses following renal transplant. Diseases of the Nervous System, 37, 663–667.

21.

Blum

(1980) Patients at risk of developing severe side-effects from depot fluphenazine treatment. American Journal of Psychiatry, 137, 254–255.

22.

Borison

R. L.

(1979) Amantadine-induced psychosis in a geriatric patient with renal disease. American Journal of Psychiatry, 136, 111–112.

23.

Boston Collaborative Drug Surveillance Programme (1971) Side-effects of non-psychiatric drugs. Seminars in Psychiatry, 3, 406–420.

24.

Bound

Greer

(1978) Psychiatric symptoms after dipipanone. Lancet, 2, 480.

25.

Boyd

A. E.

Reichlin

Turksoy

(1977) Galactorrhoeaamenorrhea syndrome: diagnosis and therapy. Annals of Internal Medicine, 87, 165–175.

26.

Brogden

R. H.

Speight

T. N.

Avery

G. S.

(1974) Baclofen: a preliminary report on pharmacological properties and therapeutic efficacy in spasticity. Drugs, 8, 1–14.

27.

Bunney

W. E.

Davis

J. M.

(1965) Norepinephrine in depressive reactions. Archives of General Psychiatry, 13, 483–494.

28.

Byrd

G. J.

Kane

F. J.

(1976) Persistent psychotic phenomena following one dose of pentazocine. Texas Medicine, 72, 68–69.

29.

Calne

D. B.

Plotkin

Williams

A. C.

Nutt

J. G.

Neophytides

Teychenne

P. F.

(1978) Long-term treatment of parkinsonism with bromocriptine. Lancet, 1, 735–738.

30.

Campbell

N. P. S.

Kelly

J. G.

Shanks

K. G.

Chaturvedi

N. C.

Storey

G. E.

Partridge

J. F.

(1973) Mexiletine in the management of ventricular dysrhythmias. Lancet, 2, 404–407.

31.

Carney

M. W. P.

(1967) Serum folate values in 423 psychiatric patients. British Medical Journal, 4, 512–516.

32.

Carney

M. W. P.

(1977) Paranoid psychosis with indomethacin. British Medical Journal, 2, 994–995.

33.

Carney

M. W. P.

Harris

(1979) Psychiatric disorder and diethylpropion hydrochloride. Pracitioner, 223, 549–552.

34.

Carney

M. W. P.

Sheffield

B. F.

(1970) Association of subnormal serum folate and vitamin B12 values and effects of replacement therapy. Journal of Nervous and Mental Disease, 150, 404–412.

35.

Carney

M. W. P.

Sheffield

B. F.

(1975) Forty-two months of experience of flupenthixol in the treatment of schizophrenia. Current Medical Research and Opinion, 3, 447–452.

36.

Cass

Alexander

Enders

(1966) Complications of corticotropin therapy in multiple sclerosis. Journal of American Medical Association, 197, 173–178.

37.

Church

Schamroth

Schwartz

N. L.

Marriott

H. J.

(1962) Deliberate digitalis intoxication: a comparison of the toxic effects of four glycoside preparations. Annals of Internal Medicine, 57, 946–956.

38.

Clark

L. D.

Quarton

G. C.

Cobb

Bauer

(1953) Further observations on mental disturbances associated with cortisone and A.C.T.H. therapy. New England Journal of Medicine, 249, 178–183.

39.

Clein

L. J.

Benady

D. R.

(1962) Case of diethylpropion addiction. British Medical Journal, 2, 456.

40.

Cohen

W. J.

Cohen

N. H.

(1974) Lithium carbonate, haloperidol and irreversible brain damage. Journal of the American Medical Association, 230, 1283–1287.

41.

Connell

P. H.

(1958) Amphetamine Psychosis. Chapman and Hall, London.

42.

Coursey

C. E.

(1978) The psychotomimetic side-effects of pentazocine. Drug Intelligence and Pharmacy, 12, 341–346.

43.

Csillag

E. R.

Landauer

A. A.

(1973) Alleged hallucinogenic effect of a toxic overdose of an antihistamine preparation. Medical Journal of Australia, 1, 653–654.

44.

Cutting

(1980) Physical illness and psychosis. British Journal of Psychiatry, 136, 109–119.

45.

Davies

R. H.

Tucker

G. J.

Harrow

Detre

T. P.

(1971) Confusional episodes and antidepressant medication. American Journal of Psychiatry, 128, 95–99.

46.

Davis

K. L.

Hollister

L. E.

Berger

P. A.

(1976) Baclofen in schizophrenia. Lancet, 1, 1245.

47.

Davison

(1978) Neurological and mental disturbances due to drugs. Age and Ageing, 7, Supplement, 119–127.

48.

de Bard

M. L.

(1979) Diazepam withdrawal syndrome. American Journal of Psychiatry, 136, 104–105.

49.

de Nosaquo

(1969) The hallucinatory effect of pentazocine. Journal of the American Medical Association, 210, 502.

50.

Drew

(1962) Concerning the side-effects of anti-malarial drugs used in the extended treatment of rheumatic disease. Medical Journal of Australia, 2, 618–620.

51.

Dysken

M. W.

Chan

C. H.

(1977) Diazepam withdrawal psychosis. American Journal of Psychiatry, 134, 573.

52.

Edison

G. R.

(1969) Hallucinations associated with pentazocine. New England Journal of Medicine, 281, 447–448.

53.

Editorial (1966) Methyldopa and hypertension. British Medical Journal, 1, 119.

54.

Editorial (1970) Depression and oral contraceptives. British Medical Journal, 4, 127–128.

55.

Editorial (1978) Antidepressants and histamine. Lancet, 1, 808.

56.

Evans

J. G.

Jarvis

E. H.

(1972) Nitrazepam and the elderly. British Medical Journal, 4, 487.

57.

Evans

L. E. J.

(1980) Psychological effects caused by drugs in overdose. Drugs, 19, 220–242.

58.

Erikssen

(1969) Atropine psychosis. Lancet, 1, 53–54.

59.

Falk

R. H.

Nisbet

P. A.

Gray

T. J.

(1977) Mental distress in patients on disopyramide. Lancet, 1, 858–859.

60.

Falk

W. E.

Mahnke

M. W.

Poskanzer

(1979) Lithium prophylaxis of corticotropin-induced psychosis. Journal of the American Medical Association, 241, 1011–1012.

61.

Flemenbaum

Gunby

(1971) Ethchlorvynol (placidyl) abuse and withdrawal. Diseases of the Nervous System, 32, 188–192.

62.

Fleminger

(1978) Visual hallucinations and illusions with propranolol. British Medical Journal, 1, 1182.

63.

Flind

A. C.

Jones

D. R.

(1979) Mental confusion with cimetidine. Lancet, 1, 379.

64.

Frazer

H. S.

Carr

A. C.

(1976) Propranolol psychosis. British Journal of Psychiatry, 129, 508–512.

65.

Freis

E. D.

(1975) Mental depression in hypertensive patients treated for long periods with large doses of reserpine. New England Journal of Medicine, 251, 1006.

66.

Fruensgaard

(1976) Withdrawal psychosis: a study of 30 consecutive cases. Acta Psychiatrica Scandinavica, 53, 105–118.

67.

Fullerton

A. G.

Boardman

R. H.

(1959) Side-effects of Tofranil. Lancet, 1, 1209–1210.

68.

Gaind

(1969) Fenfluramine (Ponderax) in the treatment of obese psychiatric outpatients. British Journal of Psychiatry, 115, 963–964.

69.

Gelenberg

A. J.

Mandel

M. R.

(1977) Catatonic reactions to high potency neuroleptic drugs. Archives of General Psychiatry, 34, 947–980.

70.

Gershon

E. S.

Goldstein

R. E.

Moss

A. J.

van Kainen

D. P.

(1979) Psychosis with ordinary doses of propranolol. Annals of Internal Medicine, 90, 938–939.

71.

Gifford

Murawski

B. J.

Kline

N. S.

Sachar

R. E.

(1976) An unusual adverse reaction to self-medication with prednisone. International Journal of Psychiatry in Medicine, 7, 97–122.

72.

Gilbert

G. J.

(1977) Quinidine dementia. Journal of the American Medical Association, 237, 2093–2094.

73.

Gonsette

R. E.

(1977) Cervical myelography with metrizamide by suboccipital puncture. Acta Radiologica, Supplement 355, 121–126.

74.

Good

M. I.

Shader

R. I.

(1977) Behavioural toxicity and equivocal suicide associated with chloroquine and its derivatives. American Journal of Psychiatry, 134, 798–801.

75.

Goodwin

F. K.

(1972) Behavioural effects of L-dopa in man. In Psychiatric Complications of Medical Drugs (ed. Shader

R. I.

) 149–174. Raven Press, New York.

76.

Goodwin

F. K.

Ebert

M. H.

Bunney

W. H.

(1972) Mental effects of reserpine in man: a review. In Psychiatric Complications of Medical Drugs (ed. Shader

R. I.

) 73–102. Raven Press. New York.

77.

Gott

P. H.

(1968) Cyclizine toxicity: intentional use of a proprietary antihistamine. New England Journal of Medicine, 279, 596.

78.

Gotz

(1978) Paranoid psychosis with indomethacin. British Medical Journal, 1, 49.

79.

Granville-Grossman

K. G.

(1971) Recent Advances in Clinical Psychiatry. 197–198 and 202–204. J. and A. Churchill, London.

80.

Greenblatt

D. T.

Shader

R. I.

(1972) Digitalis toxicity. In Psychiatric Complications of Medical Drugs (ed. Shader

R. I.

) pages 25–47. Raven Press, New York.

81.

Greenblatt

D. J.

Allen

M. D.

Shader

R. I.

(1977) Toxicity of high dose flurazepam in the elderly. Clinical Pharamacology and Therapeutics, 21, 355–361.

82.

Greer

H. D.

Ward

H. P.

Corborin

K. B.

(1965) Chronic salicylate intoxication in adults. Journal of the American Medical Association, 193, 555–558.

83.

Grimson

T. A.

(1977) Reactions to cimetidine. Lancet, 1, 858.

84.

Gupta

V. P.

Ehrlich

G. E.

(1976) Organic brain syndromes in rheumatoid arthritis following corticosteroid withdrawal. Arthritis and Rheumatism, 19, 1333–1338.

85.

Hall

R. C. W.

Popkin

M. K.

Stickney

S. K.

Gardner

E. R.

(1979) Presentation of the steroid psychoses. Journal of Nervous and Mental Disease, 167, 229–236.

86.

Hanna

S. M.

(1972) A case of oxazepam (Serenid) dependence. British Journal of Psychiatry, 120, 443–445.

87.

Hausner

R. S.

(1980) Amantadine-associated recurrence of psychosis. American Journal of Psychiatry, 137, 240–241.

88.

Harper

R. W.

Knothe

B. A. W. C.

(1973) Coloured lilliputian hallucinations with amantadine. Medical Journal of Australia, 1, 444–445.

89.

Harris

Harper

(1979) Psychosis after dextropropoxyphene. Lancet, 2, 743.

90.

Harris

Richards

D. A.

(1978) Beta-blockers in the treatment of hypertension. British Medical Journal, 2, 894.

91.

Hawkins

D. J.

(1976) Acute organic brain syndrome, psychosis with methyldopa therapy. Missouri Medicine, 73, 476–481.

92.

Helson

Duque

(1978) Acute brain syndrome after propranolol. Lancet, 1, 98.

93.

Herridge

C. F.

A'Brook

M. F.

(1968) Ephedrine psychosis. British Medical Journal, 2, 160.

94.

Heston

L. L.

Hastings

(1980) Psychosis with withdrawal from ethchlorvynol. American Journal of Psychiatry, 137, 249–250.

95.

Herzberg

B. N.

Johnson

A. L.

Brown

(1970) Depressive symptoms and oral contraceptives. British Medical Journal, 4, 142–145.

96.

Herzberg

B. N.

Draper

K. C.

Johnson

A. L.

Nichol

G. C.

(1971) Oral contraceptives, depression and libido. British Medical Journal, 3, 495–500.

97.

Hollister

L. E.

(1977) Withdrawal from benzodiazepine therapy. Journal of the American Medical Association, 237, 1432.

98.

Holmes

J. M.

(1956) Cerebral manifestations of vitamin B12 deficiency. British Medical Journal, 2, 1394–1398.

99.

Howe

J. G.

(1980) Lorazepam withdrawal seizures. British Medical Journal, 1, 1163–1164.

100.

Hua

A. A. S.

Kalowski

Whitworth

J. A.

Kincaid-Smith

(1980) Acebutalol in mild to moderate hypertension. Medical Journal of Australia, 1, 226–228.

101.

Hudson

H. S.

Walker

H. I.

(1961) Withdrawal symptoms following ethchlorvynol (Placidyl) dependence. American Journal of Psychiatry, 118, 361.

102.

Hunter

K. R.

Lawrence

D. R.

Shaw

K. M.

Stern

G. M.

(1973) Sustained levodopa therapy in parkinsonism. Lancet, 2, 929–931.

103.

Hunter

Matthews

D. M.

(1965) Mental symptoms in vitamin B12 deficiency. Lancet, 2, 738.

104.

Imlah

M. W.

(1970) Unusual effect of fenfluramine. British Medical Journal, 2, 178.

105.

Innes

J. A.

Watson

M. L.

Munro

J. F.

Stoddart

Campbell

D. B.

(1977) Plasma fenfluramine weight loss and side-effects. British Medical Journal, 2, 1322–1324.

106.

Jackson

S. L. O.

(1957) Psychosis with isoniazid. British Medical Journal, 2, 743–746.

107.

Janowsky

D. S.

el Yousef

Davis

Sekerke

H. J.

(1972) A cholinergic-adrenergic hypothesis of mania and depression. Lancet, 2, 632–633.

108.

Jefferson

J. W.

(1977) The case of the numb testicles. Journal of Clinical Psychiatry, 38, 749–751.

109.

Jefferson

J. W.

(1979) Central nervous system toxicity of cimetidine: a case of depression. American Journal of Psychiatry, 136, 346.

110.

Jefferson

J. W.

Greist

J. H.

(1977) A Primer of Lithium Therapy. Williams, Wilkins, Baltimore.

111.

Jenkins

R. B.

Groh

R. H.

(1970) Mental symptoms in parkinsonian patients treated with L-dopa. Lancet, 2, 177–180.

112.

Johnson

Kitchin

A. H.

Lawther

C. P.

Turner

R. W.

(1966) Treatment of hypertension with methyldopa. British Medical Journal, 1, 133.

113.

Johnson

Bailey

(1979) Cimetidine and psychiatric complications. British Journal of Psychiatry, 134, 315–316.

114.

Jones

H. S.

(1968) Diethylpropion dependence. Medical Journal of Australia, 1, 267.

115.

Jones

I. H.

Stevenson

Jordan

Connell

N. M.

Hetherington

H. D. G.

Gibney

G. N.

(1973) Pheniramine as an hallucinogen. Medical Journal of Australia, 1, 382–386.

116.

Kane

F. J.

Treadaway

Ewing

J. A.

(1969) Emotional changes associated with oral contraceptives in female psychiatric patients. Comprehensive Psychiatry, 10, 16–30.

117.

Kingston

(1979) Tetrabenazine for involuntary movement disorders. Medical Journal of Australia, 1, 628–629.

118.

Kinnell

H. G.

Webb

(1979) Confusion associated with cimetidine. British Medical Journal, 2, 1438.

119.

Klein

D. F.

(1965) Visual hallucinations with imipramine. American Journal of Psychiatry, 121, 911–914.

120.

Kuenssberg

E. V.

(1962) Diethylpropion. British Medical Journal, 2, 729–730.

121.

Knight

Okasha

N. S.

Salik

N. A.

Hirsch

S. R.

(1979) Depression and extrapyramidal symptoms and clinical effects with a trial of fluphenazine versus flupenthixol. British Journal of Psychiatry, 135, 515–523.

122.

Korolenko

C. P.

Yevseyeva

T. A.

Volkov

P. B.

(1969) Data for a comparative account of toxic psychoses of various aetiologies. British Journal of Psychiatry, 115, 273–279.

123.

Korsgaard

(1976) Baclofen (Lioresal) in the treatment of neuroleptic-induced tardive dyskinesia. Acta Psychiatrica Scandinavica, 54, 17–24.

124.

Kurland

M. L.

(1979) Organic brain syndrome with propranolol. New England Journal of Medicine, 300, 366.

125.

Kutner

S. J.

Brown

W. L.

(1972) Depression and contraception. Journal of Nervous and Mental Disease, 155, 153–162.

126.

Learoyd

B. M.

(1972) Psychotropic drugs in the elderly patient. Medical Journal of Australia, 1, 1131–1133.

127.

Lees

A. J.

Clarke

C. R. A.

Harrison

M. J.

(1977) Hallucinations after withdrawal of baclofen. Lancet, 1, 858.

128.

Leeton

(1974) Depression induced by oral contraceptives and the role of vitamin B6 in its management. Australian and New Zealand Journal of Psychiatry, 8, 85–88.

129.

Levin

(1975) The non-medical misuse of fenfluramine by drug dependent South Africans. Postgraduate Medical Journal, 51, Supplement 1, 186–188.

130.

Lewis

A. J.

Fleminger

J. J.

(1954) The psychiatric risk from corticotrophin and cortisone. Lancet, 1, 383–386.

131.

Lewis

Hoghughi

(1969) An evaluation of depression as a side-effect of oral contraceptives. British Journal of Psychiatry, 115, 697–701.

132.

Liddon

S. C.

Satran

(1967) Disulfiram (Antabuse) psychosis. American Journal of Psychiatry, 123, 1284.

133.

Lieberman

A. N.

Gopinathan

Estey

Kupersmith

Goodgold

Goldstein

(1979) Lergotrile in Parkinson's disease: further studies. Neurology, 29, 267–272.

134.

Linnoila

A. M.

Mattila

M. J.

Kitchell

B. S.

(1979) Drug interactions with alcohol. Drugs, 18, 299–311.

135.

Loudon

J. B.

Waring

(1976) Toxic reactions to lithium and haloperidol. Lancet, 2, 1088.

136.

Malek-Ahmadi

Behrman

P. J.

(1976) Depressive syndrome induced by oral contraceptives. Diseases of the Nervous System, 37, 406–408.

137.

Martin

E. W.

Martin

(1971) Drug-alcohol interactions. In Hazards of Medication (ed. Martin

E. W.

Martin

) pages 430–439. J. B. Lippincott, Philadelphia.

138.

McClellan

D. L.

(1972) The suppression of involuntary movements with tetrabenazine. Scottish Medical Journal, 17, 367–370.

139.

McClellan

D. L.

Chalmers

R. J.

Johnson

A. H.

(1974) A double-blind trial of tetrabenazine, thiopropazate and placebo in patients with chorea. Lancet, 1, 104–107.

140.

McClelland

H. A.

(1977) In Textbook of Adverse Drug Reactions (ed. Davis

D. M.

) pages 335–353. Oxford university Press, Oxford.

141.

McCrum

I. D.

Guidry

J. R.

(1978) Procainamide-induced psychosis. Journal of the American Medical Association, 240, 1265–1266.

142.

McMillen

M. A.

Ambis

Siegal

J. H.

(1978) Cimetidine and mental confusion. New England Journal of Medicine, 298, 284–285.

143.

Medical Letter On Drugs and Therapeutics (1980) Antabuse, 22, 1–2.

144.

Menzies-Gow

(1977) Cimetidine and mental confusion. Lancet, 2, 928.

145.

Millac

Hasan

Espir

M. L. E.

Slyfield

D. G.

(1970) Amantadine in Parkinson's disease. Lancet, 1, 464.

146.

Miller

R. R.

(1976) Meperidine hydrochloride. In Drug Effects on Hospitalized Patients (ed. Miller

R. R.

Greenblatt

D. J.

) pages 144–148. John Wiley and Sons, New York.

147.

Miller

R. R.

Greenblatt

D. J.

(1976) Drug Effects on Hospitalized Patients. John Wiley and Sons, New York.

148.

Muller

J. C.

Pryor

W. W.

Gibbons

J. E.

Orgain

E. S.

(1955) Depression and anxiety occurring during rawolfia therapy. Journal of the American Medical Association, 159, 839.

149.

Mumenthaler

Kaeser

A. J.

Meyer

Hess

(1979) Transient global amnesia after clioquinol. Journal of Neurology, Neurosurgery and Psychiatry, 42, 1084–1090.

150.

Murray

R. M.

Greene

J. G.

Adams

J. H.

(1971) Analgesic abuse and dementia. Lancet, 2, 242–245.

151.

Meyler

Herxheimer

(1972) Side-effects of Drugs. Volume 7. Excerpta Medica, Amsterdam.

152.

Meyler'S Side-Effects Of Drugs (1975) Volume 8. (ed. Dukes

M. N. G.

). Excerpta Medica, Amsterdam.

153.

Meyler'S Side-Effects Of Drugs Annual (1977, 1978, 1979) (ed. Dukes

M. N. G.

). Excerpta Medica, Amsterdam.

154.

Nelson

J. C.

Bowers

N. B.

Sweeney

P. R.

(1979) Exacerbation of psychosis by tricyclic antidepressants in delusional depression. American Journal of Psychiatry, 136/4B, 574–576.

155.

Nelson

P. G.

(1977) Cimetidine and mental confusion. Lancet, 2, 928.

156.

New Zealand Hypertension Study Group (1977) Initial experiences with prasozin in New Zealand. Medical Journal of Australia, Supplement 1, 23–26.

157.

Nies

A. S.

(1977) Clinical pharmacology of antihypertensive drugs. Medical Clinics of North America, 61, 675–698.

158.

Nigro

S. A.

(1968) Toxic psychosis due to diphenhydramine hydrochloride (Benadryl). Journal of the American Medical Association, 203, 301–302.

159.

Nillson

Jacobson

Ingemansson

C-A.

(1967) Side-effects of an oral contraceptive with particular attention to mental symptoms and sexual adaptation. Acta Obstetrica and Gynaecologica Scandinavica, 46, 537–556.

160.

Novenius

Widerlöv

Lönnerholm

(1979) Phenylpropanolamine and mental disturbances. Lancet, 2, 1367–1368.

161.

O'Brien

W. M.

(1968) Indomethacin: a survey of clinical trials. Clinical Pharmacology and Therapeutics, 9, 94–107.

162.

Oswald

(1974) Fenfluramine and psychosis. British Medical Journal, 4, 103.

163.

Ovesen

(1979) Vitamin deficiencies and drugs. Drugs, 18, 278–298.

164.

Parkes

J. D.

(1979) Bromocriptine in the treatment of parkinsonism. Drugs, 17, 365–382.

165.

Parry

D. L.

Rush

(1979) Oral contraceptives and depressive symptomatology. Comprehensive Psychiatry, 20, 347–358.

166.

Paykel

E. S.

Coppen

(1979) Psychopharmacology of Affective Disorders. Oxford University Press, London.

167.

Pearlman

C. A.

(1971) Manic behaviour with L-dopa. New England Journal of Medicine, 285, 1326.

168.

Petite

J. P.

Bloch

(1979) Syndrome depressif au cours du traitement par cimétidine. Nouvelle Presse Medicale, 8, 1260.

169.

Peturson

(1979) Diethylpropion and paranoid psychosis. Australian and New Zealand Journal of Psychiatry, 13, 67–68.

170.

Pevnick

J. S.

Jasinki

D. R.

Haertzen

C. A.

(1978) Abrupt withdrawal from therapeutically administered diazepam. Archives of General Psychiatry, 35, 995–998.

171.

de Pinto

O. S.

Polikar

Debono

(1972) Results of international clinical trial of Lioresal. Postgraduate Medical Journal, 48, Supplement (October), 18–23.

172.

Postama

T. W.

van Tillburg

(1975) Visual hallucinations and delirium during treatment with amantadine (Symmetrel). Journal of the American Geriatric Society, 23, 212–215.

173.

Preskorn

S. H.

Denner

L. E.

(1977) Benzoidiazepines and withdrawal psychosis. Journal of the American Medical Association, 237, 36–38.

174.

Rampling

(1978) Aggression: a paradoxical response to tricyclic antidepressants. American Journal of Psychiatry, 135, 117–118.

175.

Reisberg

(1978) Catatonia associated with disulfiram therapy. Journal of Nervous and Mental Disease, 166, 607–609.

176.

Restak

R. M.

(1972) Pseudotumor cerebri, psychosis and hypervitaminosis A. Journal of Nervous and Mental Disease, 155, 72–75.

177.

Reynolds

E. H.

(1975) Chronic anti-epileptic toxicity. Epilepsia, 16, 319–352.

178.

Reynolds

E. H.

Preece

J. M.

Bailey

Coppen

(1970) Folate deficiency in depressive illness. British Journal of Psychiatry, 117, 287–292.

179.

Robinson

B. F.

(1975) Drugs acting on the cardiovascular system. In Meyler's Side-effects of Drugs Volume 8 (ed. Dukes

M. N. G.

) 428–460. Excerpta Medica, Amsterdam.

180.

Robinson

R. G.

(1966) Indomethacin in rheumatic disease: a reassessment. Medical Journal of Australia, 1, 971–972.

181.

Rosenfield

A. A.

(1979) Depression and psychotic regression following prolonged methylphenidate use and withdrawal: case report. American Journal of Psychiatry, 136, 226–228.

182.

Ross

R. R.

(1958) Use of pyridoxine hydrochloride to prevent isoniazid toxicity. Journal of the American Medical Association, 168, 273–275.

183.

Routledge

P. A.

(1977) Adverse reactions to drug withdrawal. Adverse Drug Reaction Bulletin, 47, 236–239.

184.

Royal College Of General Practitioners (1974) Oral Contraceptives and Health. Pitman Medical, Manchester.

185.

Roxanas

M. G.

Spalding

(1977) Ephedrine abuse psychosis. Medical Journal of Australia, 2, 639–640.

186.

Ryback

R. S.

Schwab

R. S.

(1971) Manic response to levodopa therapy. New England Journal of Medicine, 255, 788–789.

187.

Salamanthan

G. L.

Gershon

(1973) Imipramine withdrawal: an akathesia-like syndrome. American Journal of Psychiatry, 130, 1286–1287.

188.

Santos

A. B.

McCurdy

(1980) Delirium after abrupt withdrawal from doxepin. American Journal of Psychiatry, 137, 239–240.

189.

Schentag

J. J.

Calleri

Rose

J. Q.

Serra

F. B.

de Glopper

Benhard

(1979) Pharmacokinetic and clinical studies in patients with cimetidine-associated mental confusion. Lancet, 1, 177–181.

190.

Schildkraut

J. J.

(1965) The catecholamine hypothesis of affective disorder: a review of supporting evidence. American Journal of Psychiatry, 122, 509–522.

191.

Schroeder

H. A.

Perry

H. M.

(1955) Psychosis apparently produced by reserpine. Journal of the American Medical Association, 159, 839–840.

192.

Schwab

R. S.

England

A. C.

Poskanzer

D. C.

Young

R. R.

(1969) Amantadine in the treatment of Parkinson's disease. Journal of the American Medical Association, 208, 1168–1170.

193.

Senby

Angrist

Lieberman

(1978) Mental disturbances during bromocriptine and lergotrile treatment of Parkinson's disease. American Journal of Psychiatry, 135, 1227–1229.

194.

Shader

R. I.

(1972) Psychiatric Complications of Medical Drugs. Raven Press, New York.

195.

Shannon

P. J.

Leonard

Kidson

M. A.

(1974) Fenfluramine and psychosis. British Medical Journal, 3, 576.

196.

Shatan

(1966) Withdrawal symptoms from abrupt termination of imipramine. Canadian Psychiatric Association Journal, 11, Special Supplement, 150–158.

197.

Silverstone

Turner

(1974) Drug Treatment in Psychiatry. Routledge and Kegan Paul, London.

198.

Simpson

F. O.

Waal-Manning

H. J.

(1971) Hypertension and depression. Journal of the Royal College of Physicians of London, 6, 14–24.

199.

Siomopoulos

(1975) Amphetamine psychosis: overview and an hypothesis. Diseases of the Nervous System, 36, 336–339.

200.

Snaith

R. P.

Mehta

Raby

A. N.

(1970) Serum folate and vitamin B12 in epileptics with and without mental illness. British Journal of Psychiatry, 116, 179–183.

201.

Snaith

R. P.

McCourbie

(1974) Antihypertensive drugs and depression. Psychological Medicine, 4, 393–398.

202.

Sortland

Lundervold

Nisbakken

(1977) Mental confusion and epileptic seizures after cervical myelography with metrizamide. Acta Radiologica, Supplement 355, 403–406.

203.

Stein

(1977) Hallucinations after sudden withdrawal of baclofen. Lancet, 2, 1381.

204.

Steinert

Pugh

C. R.

(1979) Two patients with schizophrenia-like psychoses after treatment with beta-adrenergic agents. British Medical Journal, 1, 799.

205.

Stephens

D. A.

(1967) Psychotoxic effects of benzhexol. British Journal of Psychiatry, 113, 213–218.

206.

Swash

Roberts

A. H.

Zakho

Heathfield

K. W. G.

(1972) Treatment of involuntary movement disorders with tetrabenazine. Journal of Neurology, Neurosurgery and Psychiatry, 35, 186–191.

207.

Taylor

Galloway

D. B.

Petrie

J. C.

Davidson

J. F.

Gallon

S. C.

Moir

D. C.

(1978) Psychomimetic effects of pentazocine. British Medical Journal, 2, 1198.

208.

Toglia

J. W.

McGlamery

Sanbandham

R. R.

(1978) Tetrabenazine in the treatment of Huntington's chorea and other hyperkinetic movement disorders. Journal of Clinical Psychiatry, 39, 81–87.

209.

Thompson

M. K.

(1979) Schizophrenia-like psychosis after treatment with beta-blockers. British Medical Journal, 1, 1084–1085.

210.

Thompson

Perry

J. S.

(1966) Further experience with indomethacin in the treatment of rheumatic disease. British Medical Journal, 1, 80–83.

211.

Thornton

W. E.

(1976) Dementia induced by methyldopa with haloperidol. New England Journal of Medicine, 294, 1222.

212.

Topliss

Bond

(1977) Acute brain syndrome after propranolol. Lancet, tex2, 1133.

213.

Trimble

M. R.

Reynolds

E. H.

(1976) Anticonvulsant drugs and mental symptoms. Psychological Medicine, 6, 169–178.

214.

van Praag

H. M.

(1978) Psychotropic drugs. McMillan Press, London.

215.

Verbist

Pignot

Cosemans

(1966) Tolerance of ethionamide and PAS in original treatment of tuberculous patients. Scandinavian Journal of Respiratory Disease, 47, 225–235.

216.

Waal

H. J.

(1967) Propranolol-induced depression. British Medical Journal, 2, 50.

217.

Wallach

M. B.

Gershon

(1972) Psychiatric sequelae to tuberculosis therapy. In Psychiatric Complications of Medical Drugs (ed. Shader

R. I.

) pages 201–202. Raven Press, New York.

218.

Weinberger

D. R.

Kelly

M. J.

(1977) Catatonia and malignant syndrome: a possible complication of neuroleptic administration. Journal of Nervous and Mental Disease, 165, 263–268.

219.

Whitlock

F. A.

(1970) The syndrome of barbiturate dependence. Medical Journal of Australia, 2, 391–396.

220.

Whitlock

F. A.

Bonfield

A. R.

(1980) Propranolol psychosis. Medical Journal of Australia, 1, 184–185.

221.

Whitlock

F. A.

Evans

L. E. J.

(1978) Drugs and depression. Drugs, 15, 53–71.

222.

Whitlock

F. A.

Fama

P. G.

(1966) Hyoscine poisoning in psychiatric patients. Medical Journal of Australia, 2, 763–764.

223.

Whitlock

F. A.

Nadorfi

M. I.

(1970) Diethylpropion and psychosis. Medical Journal of Australia, 2, 1097.

224.

Winokur

Rickels

Greenblatt

E. J.

(1980) Withdrawal reaction from long-term low dosage administration of diazepam. Archives of General Psychiatry, 37, 101–105.

225.

Wood

L. A.

Moir

D. C.

Campbell

Davidson

J. F.

Gallon

S. C.

Henney

McAllion

(1974) Medicine evaluation monitoring group; central nervous system effects of pentazocine. British Medical Journal, 1, 305–307.

226.

Woody

G. E.

O'Brien

C. P.

Greenstein

(1975) Misuse and abuse of diazepam: an increasingly common medical problem. International Journal of Addictions, 10, 843–848.